Bioethics Blogs

Health Law Classes Online J Term 2017

Legal Compliance Essentials for Drug, Device, and Biotech Companies

.
January 2-13, 2017
Online
2 J.D. credits
Approved for 15 on-demand standard CLE credits (event code: 227898)
Approved for 15 Regulatory Affairs Certification (RAC) Credits.
The Compliance Certification Board (CCB)® has approved this event for up to 10.8 CCB CEUs. Continuing Education Units are awarded based on individual attendance records. Granting of prior approval in no way constitutes endorsement by CCB of this program content or of the program sponsor

Faculty

Dr. Seth Whitelaw, J.D., Founder, Whitelaw Compliance Group, LLCSenior Fellow and Adjunct Professor, Life Sciences Compliance
Description

ccb-logo

The U.S. health care system is composed of three primary parts: providers, payers, and finally manufacturers (drug, device, and biotech companies). It is a complex, complicated, and challenging system of laws, regulations, cases, guidance and, in some cases, folklore. This course is designed for the current and future attorney or compliance professional supporting drug, device, and biotech companies. Students will gain a practical understanding of the laws, regulations, cases, and guidance they will encounter in daily practice. Also, upon completion, all participants will understand how to design and operate an effective company compliance program.

Textbook

O’Reilly, et. al, Food and Drug Administration, 4th ed. (can be accessed online via Westlaw)
Holland & Knight, Corporate Compliance Answer Book 2017, Practicing Law Institute

From Addiction to Zika: Current Issues in Public Health Law

Jill Krueger, J.D.
January 2-13, 2017
Online
2 J.D. credits
Faculty

Description

This course explores public health law through the lens of current issues in population health.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.